YUM DONE AND
DOGS PREFER *1
SIMPARICA TRIO ® (sarolaner, moxidectin, and pyrantel chewable tablets).
OVER
IMPORTANT SAFETY INFORMATION: NexGard ® PLUS (afoxolaner, moxidectin, and pyrantel chewable tablets) is for use in dogs only. The most frequently reported adverse reactions reported in clinical trials were diarrhea, vomiting, lethargy, and itching. NexGard PLUS contains afoxolaner, a member of the isoxazoline class, which has been associated with neurologic adverse reactions including tremors, ataxia, and seizures in dogs with or without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. The safe use of NexGard PLUS has not been evaluated in breeding, pregnant, or lactating dogs. Dogs should be tested for existing heartworm infection prior to starting a heartworm disease preventive. For more information, see full prescribing information or visit NexGardPLUSClinic.com
* In a study, for dogs that demonstrated a preference, they preferred NexGard ® PLUS over SIMPARICA TRIO®.
1. Data on file at Boehringer Ingelheim.
NexGard ® is a registered trademark of Boehringer Ingelheim Animal Health France, used under license. All other trademarks are the property of their respective owner. ©2024 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved. US-PET-1007-2023
Made with FlippingBook - professional solution for displaying marketing and sales documents online